Bardet-Biedl Syndrome 4 (BBS4) Peptid
BBS4
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle BBS4 Produkte
- BBS4 (Bardet-Biedl Syndrome 4 (BBS4))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- LGIYQKAFEH LGNALTYDPT NYKAILAAGS MMQTHGDFDV ALTKYRVVAC
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BBS4 antibody,
Alternative Names: BBS4 control peptide, BBS4 antibody Blocking Peptide, Anti-BBS4 Blocking Peptide, Bardet-Biedl Syndrome 4 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- BBS4 (Bardet-Biedl Syndrome 4 (BBS4))
- Hintergrund
- This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and mental retardation. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport.
- Molekulargewicht
- 58 kDa
-
Sie sind hier:
